Bio-Reference Laboratories Inc  

(Public, NASDAQ:BRLI)   Watch this stock  
Find more results for BRLI
Aug 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 26.32 - 47.49
Open     -
Vol / Avg. 0.00/387,653.00
Mkt cap 962.26M
P/E 19.05
Div/yield     -
EPS 1.82
Shares 27.80M
Beta 0.76
Inst. own 74%
Aug 25, 2015
Q3 2015 Bio-Reference Laboratories Inc Earnings Release (Estimated)
Aug 20, 2015
Bio-Reference Laboratories Inc Extraordinary Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2014
Net profit margin 4.67% 5.62%
Operating margin 8.45% 10.02%
EBITD margin - 13.05%
Return on average assets 8.38% 10.39%
Return on average equity 12.67% 15.84%
Employees 3,406 -
CDP Score - -


481 Edward H Ross Dr
ELMWOOD PARK, NJ 07407-3118
United States - Map
+1-201-7912186 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.